Top Markets
Coin of the day
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Rankning i aktier #28678
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Aktiekurs
$0.07339369
Senast synkroniserad: 2026-08-18
Marknadsvärde
$25.24M
Förändring (1 dag)
5.26%
Förändring (1 år)
-7.44%
Land
CA
Handel Resverlogix Corp. (RVX)

Kategori

Historik för aktiesplit för Resverlogix Corp. (RVX)
Aktien Resverlogix Corp. (symbol: RVX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En RVX-aktie köpt före Aug 20, 2026 motsvarar nu 0 RVX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH